Embolization particle, non-bioabsorbable
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
19-10-2022
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
Boston Scientific Pty Ltd
Class:
Class IIb
Manufactured by:
Boston Scientific Corporation 300 Boston Scientific Way, Marlborough, MA, 01752 United States Of America
Therapeutic area:
60938 - Embolization particle, non-bioabsorbable
Therapeutic indications:
Used for the embolization of peripheral hypervascular tumors, including leiomyoma uteri and peripheral arteriovenous malformations (AVMs).
Authorization status:
A
Authorization date:
2022-07-08
